{"title":"Treatment of 23 spinal perimedullary arteriovenous fistulas in a single center: A simple and practical treatment strategy.","authors":"Hon-Man Liu, Chung-Wei Lee, Yen-Heng Lin","doi":"10.25259/SNI_133_2025","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The aim of the study is to present our strategy for stratifying patients with spinal perimedullary arteriovenous fistulas (PMAVFs) and apply the appropriate treatment.</p><p><strong>Methods: </strong>This retrospective study included 23 patients with PMAVF. We divided the patients into three groups according to the location of the fistula and size of the predominant feeder: Group 1 (dorsal PMAVF, <i>n</i> = 4), Group 2 (nondorsal PMAVF having a predominant feeder through which the smallest coil-deploying microcatheter could pass, <i>n</i> = 6), and Group 3 (nondorsal PMAVF having no feeder through which the smallest available microcatheter could pass, <i>n</i> = 13). Group 1 underwent surgical treatment. All patients in Groups 2 and 3 underwent endovascular treatment with a liquid embolic agent, except one in Group 3, who opted for surgical treatment. Coil was used as a supplementary tool for treating lesions in Group 2. Patients' basic and clinical characteristics, treatment, and outcome data were recorded.</p><p><strong>Results: </strong>Six patients were aged <15 years. Overall, patient fistulas were located in the thoracic region (<i>n</i> = 11), conus region (<i>n</i> = 7), and cervical spine (<i>n</i> = 5). Of the 18 PMAVFs who underwent endovascular treatment, 100% occlusion was observed in 14, 90% in 3, and 75% in 1. Nineteen patients had complete or partial recovery of neurological deficits. Six patients experienced temporary worsening immediately after treatment but recovered within 3 months. No bleeding or rebleeding was noted after either treatment.</p><p><strong>Conclusion: </strong>Our simple strategy for stratifying PMAVF for treatment is easy to apply in clinical practice and results in favorable outcomes.</p>","PeriodicalId":94217,"journal":{"name":"Surgical neurology international","volume":"16 ","pages":"196"},"PeriodicalIF":0.0000,"publicationDate":"2025-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12134828/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Surgical neurology international","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.25259/SNI_133_2025","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background: The aim of the study is to present our strategy for stratifying patients with spinal perimedullary arteriovenous fistulas (PMAVFs) and apply the appropriate treatment.
Methods: This retrospective study included 23 patients with PMAVF. We divided the patients into three groups according to the location of the fistula and size of the predominant feeder: Group 1 (dorsal PMAVF, n = 4), Group 2 (nondorsal PMAVF having a predominant feeder through which the smallest coil-deploying microcatheter could pass, n = 6), and Group 3 (nondorsal PMAVF having no feeder through which the smallest available microcatheter could pass, n = 13). Group 1 underwent surgical treatment. All patients in Groups 2 and 3 underwent endovascular treatment with a liquid embolic agent, except one in Group 3, who opted for surgical treatment. Coil was used as a supplementary tool for treating lesions in Group 2. Patients' basic and clinical characteristics, treatment, and outcome data were recorded.
Results: Six patients were aged <15 years. Overall, patient fistulas were located in the thoracic region (n = 11), conus region (n = 7), and cervical spine (n = 5). Of the 18 PMAVFs who underwent endovascular treatment, 100% occlusion was observed in 14, 90% in 3, and 75% in 1. Nineteen patients had complete or partial recovery of neurological deficits. Six patients experienced temporary worsening immediately after treatment but recovered within 3 months. No bleeding or rebleeding was noted after either treatment.
Conclusion: Our simple strategy for stratifying PMAVF for treatment is easy to apply in clinical practice and results in favorable outcomes.